Comparative outcomes with low-dose and standard-dose immune checkpoint inhibitors in microsatellite stable advanced gastric/gastroesophageal adenocarcinoma.

Ramaswamy A, Shenoy V, Bahl A, Rauthan A, Krishna VM, Talwar V, Agarwala V, Kapoor A, Pinninti R, Sharma M, Rajappa SJ, Rohatgi N, Khan A, Jain A, Batra U, Kaushal RK, Chandrakanth MV, Sansar B, Gupta A, Bhargava P, Ostwal V

Open source

DOI: 10.1016/j.esmogo.2026.100302
Published: 2026 Mar
Container: ESMO gastrointestinal oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.esmogo.2026.100302,
  title = {Comparative outcomes with low-dose and standard-dose immune checkpoint inhibitors in microsatellite stable advanced gastric/gastroesophageal adenocarcinoma.},
  author = {Ramaswamy A and Shenoy V and Bahl A and Rauthan A and Krishna VM and Talwar V and Agarwala V and Kapoor A and Pinninti R and Sharma M and Rajappa SJ and Rohatgi N and Khan A and Jain A and Batra U and Kaushal RK and Chandrakanth MV and Sansar B and Gupta A and Bhargava P and Ostwal V},
  year = {2026},
  journal = {ESMO gastrointestinal oncology},
  doi = {10.1016/j.esmogo.2026.100302},
  url = {https://doi.org/10.1016/j.esmogo.2026.100302}
}

RIS

TY  - JOUR
TI  - Comparative outcomes with low-dose and standard-dose immune checkpoint inhibitors in microsatellite stable advanced gastric/gastroesophageal adenocarcinoma.
AU  - Ramaswamy A
AU  - Shenoy V
AU  - Bahl A
AU  - Rauthan A
AU  - Krishna VM
AU  - Talwar V
AU  - Agarwala V
AU  - Kapoor A
AU  - Pinninti R
AU  - Sharma M
AU  - Rajappa SJ
AU  - Rohatgi N
AU  - Khan A
AU  - Jain A
AU  - Batra U
AU  - Kaushal RK
AU  - Chandrakanth MV
AU  - Sansar B
AU  - Gupta A
AU  - Bhargava P
AU  - Ostwal V
PY  - 2026
JO  - ESMO gastrointestinal oncology
DO  - 10.1016/j.esmogo.2026.100302
UR  - https://doi.org/10.1016/j.esmogo.2026.100302
ER  -

APA

A, R., V, S., A, B., A, R., VM, K., V, T., V, A., A, K., R, P., M, S., SJ, R., N, R., A, K., A, J., U, B., RK, K., MV, C., B, S., A, G., P, B., & V, O. (2026). Comparative outcomes with low-dose and standard-dose immune checkpoint inhibitors in microsatellite stable advanced gastric/gastroesophageal adenocarcinoma.. ESMO gastrointestinal oncology. https://doi.org/10.1016/j.esmogo.2026.100302

Source records

pubmed · retrieved 2026-09-27T08:13:27.372Z